Title for MeetingAbstracts
Alphabetical listing of titles
Anti-HIV-1 activity of 3'-azido-2',3'-dideoxythymidine (AZT) in primary mononuclear phagocytes.
Anti-HIV-1 activity of 3'-fluoro-3'-deoxythymidine for different multidrug-resistant mutants.
Anti-HIV-1 activity of a commonly used Chinese traditional herb DS in vitro and in vivo. Eleventh International Conference on Antiviral Research.
Anti-HIV-1 activity of and HIV-1 resistance profiles against JE-2147 (KNI-764), a novel inhibitor of HIV-1 protease.
Anti-HIV-1 activity of CD4 synthetic oligopeptides.
Anti-HIV-1 activity of CD4 synthetic oligopeptides.
Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged albumins and AZT.
Anti-HIV-1 activity of FLT: preliminary results from a clinical trial.
Anti-HIV-1 activity of Labiatae plants, especially aromatic plants.
Anti-HIV-1 Activity of TAK-220, a Small Molecule CCR5 Antagonist.
Anti-HIV-1 activity of the extract of Fuscoporia obliqua.
Anti-HIV-1 activity, toxicity and pharmacokinetics of totally novel nucleoside analogs.
Anti-HIV-1 anti-inflammatory activities of a new glutathione-replenishing drug in HIV-1 infected macrophages.
Anti-HIV-1 assay performance: interlot and intralot variability. Australian HIV Testing Laboratories.
Anti-HIV-1 bis naphthalenesulfonic acid analogs. Structure activity relationship studies.
Anti-HIV-1 CD4[+]and CD8[+]T-Cell Responses in Chronically HIV-1-Infected Patients Treated with HAART: Relevance for Specific Immunotherapy.
Anti-HIV-1 combination effects of antisense oligonucleotide (S-dC-28) with AZT, interferon alpha (IFN) and dextran sulfate-8000 (DS).
Anti-HIV-1 combination therapy in monocyte/macrophages.
Anti-HIV-1 cytotoxic T lymphocyte effector (CTLe) activity and disease progression during early HIV-1 infection.
Anti-HIV-1 gene therapy using packageable multimeric ribozymes.
Anti-HIV-1 IgA in culture supernates detected by recombinant dot blot assay.
Anti-HIV-1 IgG in urine detected by sensitive enzyme immunoassay for diagnosis of HIV-1 infection.
Anti-HIV-1 kits inter- and intralot performance evaluation.
Anti-HIV-1 p24 antibody reactivity as a predictor of maternal-infant HIV-1 transmission.
Anti-HIV-1, Anti-Inflammatory and Neuroprotective Potentials of PAF Antagonists.
Anti-HIV-1/2 assay with increased detection to group O by addition of group O recombinant antigens.
Anti-HIV-IgG productions in vitro during virus isolation.
Anti-HIV1 protective reactivity mediated by monoclonal antibodies against p24-core-protein.
Anti-HIV1/2 and anti-HTL VI/II antibodies in Italian thalassemics.
Anti-HLA antibodies in AIDS patients.